BioCentury
ARTICLE | Company News

AZ, Champions Oncology partner to develop novel cohorts of PDX models

September 1, 2017 3:12 PM UTC

AstraZeneca plc (LSE:AZN; NYSE:AZN) and Champions Oncology Inc. (NASDAQ:CSBR) partnered to develop two novel cohorts of patient-derived xenograft (PDX) models. AstraZeneca will utilize the models in...

BCIQ Target Profiles

EGFR